PE20040761A1 - Compuestos de pirrolotriazona - Google Patents

Compuestos de pirrolotriazona

Info

Publication number
PE20040761A1
PE20040761A1 PE2003000494A PE2003000494A PE20040761A1 PE 20040761 A1 PE20040761 A1 PE 20040761A1 PE 2003000494 A PE2003000494 A PE 2003000494A PE 2003000494 A PE2003000494 A PE 2003000494A PE 20040761 A1 PE20040761 A1 PE 20040761A1
Authority
PE
Peru
Prior art keywords
triazin
aminopropyl
oxo
alkenyl
benzyl
Prior art date
Application number
PE2003000494A
Other languages
English (en)
Inventor
Rajeev S Bhide
Songfeng Lu
Louis J Lombardo
Kyoung S Kim
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20040761A1 publication Critical patent/PE20040761A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, SUS ENANTIOMEROS, DIASTEREOMEROS, SALES, PROFARMACOS Y SOLVATOS, DONDE Y1, Y2, Y3 SON CADA UNO H, HALOGENO, -CN, ALQUILO, ENTRE OTROS; Z ES O, S; R1 ES H, ALQUENILO, ALQUINILO, ARILO, ENTRE OTROS; R2 Y R3 SON CADA UNO H, HALOGENO, CICLOALQUILO, ALQUENILO, ALQUINILO, O TOMADOS JUNTOS SON UN ANILLO CARBOCICLICO O HETEROCICLICO DE 3 A 8 ATOMOS; n ES 0-4; A ES O, S O N, Y CUANDO A SEA O O S: R5 NO EXISTA; R4 Y R5 SON CADA UNO H, ALQUENILO, CICLOALQUILO, HETEROARILO, ARALQUILO. SON COMPUESTOS PREFERIDOS: SAL DE ACIDO TRIFLUOROACETICO DE (+-)-N-(3-AMINOPROPIL)-N-[1-(3-BENCIL-4-OXO-3,4-DIHIDROPIRROLO[2,1-f][1,2,4]-TRIAZIN-2-IL)-PROPIL]-4-METILBENZAMIDA; SAL DE ACIDO TRIFLUOROACETICO (+-)-N-(3-AMINOPROPIL)-N-[1-(3-BENCIL-5-CLORO-4-OXO-3,4-DIHIDROPIRROLO[2,1-f][1,2,4]-TRIAZIN-2-IL)-PROPIL]-4-METILBENZAMIDA Y SAL DE ACIDO TRIFLUOROACETICO (+-)-N-(3-AMINOPROPIL)-N-[1-(3-BENCIL-4-OXO-3,4-DIHIDRO-PIRROLO[2,1-f][1,2,4]-TRIAZIN-2-IL)-PROPIL]-4-CLORO-BENZAMIDA; ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS COMO CANCER
PE2003000494A 2002-05-21 2003-05-21 Compuestos de pirrolotriazona PE20040761A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38219702P 2002-05-21 2002-05-21

Publications (1)

Publication Number Publication Date
PE20040761A1 true PE20040761A1 (es) 2004-11-20

Family

ID=29584372

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000494A PE20040761A1 (es) 2002-05-21 2003-05-21 Compuestos de pirrolotriazona

Country Status (7)

Country Link
US (1) US7030118B2 (es)
EP (1) EP1519729A1 (es)
AR (1) AR040081A1 (es)
AU (1) AU2003239568A1 (es)
PE (1) PE20040761A1 (es)
TW (1) TW200407143A (es)
WO (1) WO2003099286A1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670357B2 (en) * 2000-11-17 2003-12-30 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
US6867300B2 (en) 2000-11-17 2005-03-15 Bristol-Myers Squibb Company Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
CA2468266A1 (en) 2001-12-06 2003-06-19 Merck & Co., Inc. Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
US20060014741A1 (en) * 2003-12-12 2006-01-19 Dimarco John D Synthetic process, and crystalline forms of a pyrrolotriazine compound
US7102001B2 (en) * 2003-12-12 2006-09-05 Bristol-Myers Squibb Company Process for preparing pyrrolotriazine
MY145634A (en) 2003-12-29 2012-03-15 Bristol Myers Squibb Co Pyrrolotriazine compounds as kinase inhibitors
US7064203B2 (en) 2003-12-29 2006-06-20 Bristol Myers Squibb Company Di-substituted pyrrolotriazine compounds
US7459562B2 (en) 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
US7102002B2 (en) * 2004-06-16 2006-09-05 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7173031B2 (en) 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7102003B2 (en) * 2004-07-01 2006-09-05 Bristol-Myers Squibb Company Pyrrolotriazine compounds
US7504521B2 (en) 2004-08-05 2009-03-17 Bristol-Myers Squibb Co. Methods for the preparation of pyrrolotriazine compounds
PE20060421A1 (es) 2004-08-12 2006-06-01 Bristol Myers Squibb Co Procedimiento para preparar un compuesto de pirrolotriazina anilina como inhibidores de cinasa
CA2575188A1 (en) 2004-08-18 2006-02-23 Astrazeneca Ab Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
US7151176B2 (en) * 2004-10-21 2006-12-19 Bristol-Myers Squibb Company Pyrrolotriazine compounds
US8875040B2 (en) * 2005-06-07 2014-10-28 Rockwell Automation Technologies, Inc. Universal web-based reprogramming method and system
JP2008524331A (ja) * 2004-12-21 2008-07-10 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
US7232901B2 (en) 2005-07-01 2007-06-19 Bristol-Myers Squibb Company Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates
PT1942898E (pt) 2005-09-14 2011-12-20 Takeda Pharmaceutical Inibidores da dipeptidilpeptidase para o tratamento da diabetes
JP5122462B2 (ja) 2005-09-16 2013-01-16 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
US7514435B2 (en) * 2005-11-18 2009-04-07 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US8063208B2 (en) 2006-02-16 2011-11-22 Bristol-Myers Squibb Company Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
TW200902019A (en) 2007-04-26 2009-01-16 Ono Pharmaceutical Co Dicyclic heterocyclic compound
EP2070932A1 (en) * 2007-12-13 2009-06-17 4Sc Ag Pyrazolotriazines
EP2376491B1 (en) 2008-12-19 2015-03-04 Cephalon, Inc. Pyrrolotriazines as alk and jak2 inhibitors
ME03782B (me) 2011-04-08 2021-04-20 Janssen Sciences Ireland Unlimited Co Derivati pirimidina za tretman virusnih infekcija
EP2518070A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Pyrrolotriazinone derivatives as PI3K inhibitors
CN107011346B (zh) 2011-11-09 2020-06-16 爱尔兰詹森科学公司 用于治疗病毒感染的嘌呤衍生物
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
BR112015000615B1 (pt) 2012-07-13 2022-05-31 Janssen Sciences Ireland Uc Purinas macrocíclicas para o tratamento de infecções virais e composição farmacêutica que as compreende
WO2014015523A1 (en) * 2012-07-27 2014-01-30 Hutchison Medipharma Limited Novel heteroaryl and heterocycle compounds, compositions and methods
CN104837840B (zh) 2012-10-10 2017-08-08 爱尔兰詹森科学公司 用于治疗病毒感染及其他疾病的吡咯并[3，2‑d]嘧啶衍生物
WO2014060432A1 (en) * 2012-10-16 2014-04-24 Almirall, S.A. Pyrrolotriazinone derivatives as pi3k inhibitors
AU2013346793B2 (en) 2012-11-16 2018-03-08 Janssen Sciences Ireland Uc Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
KR102300861B1 (ko) 2013-02-21 2021-09-10 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
JP6336036B2 (ja) 2013-03-29 2018-06-06 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染治療のための大環状デアザプリノン
JP6377139B2 (ja) 2013-05-24 2018-08-22 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染症およびさらなる疾患の処置のためのピリドン誘導体
PL3030563T3 (pl) 2013-06-27 2018-01-31 Janssen Sciences Ireland Uc Pochodne pirolo [3,2-d] pirymidyny do leczenia zakażeń wirusowych i innych chorób
MX368625B (es) 2013-07-30 2019-10-08 Janssen Sciences Ireland Uc Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales.
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EA201690713A1 (ru) 2013-10-04 2016-08-31 Инфинити Фармасьютикалз, Инк. Гетероциклические соединения и их применения
CA2943075C (en) 2014-03-19 2023-02-28 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
NZ740616A (en) 2015-09-14 2023-05-26 Infinity Pharmaceuticals Inc Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
JP6896715B2 (ja) 2015-09-30 2021-06-30 マックス−プランク−ゲゼルシャフト ツール フェルデルング デル ヴィッセンシャフテン エーファウ −ジェネラルフェルヴァルトゥング セピアプテリン還元酵素としてのヘテロアリール誘導体
CA3001728A1 (en) 2015-11-16 2017-05-26 Topadur Pharma Ag 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2018002319A1 (en) 2016-07-01 2018-01-04 Janssen Sciences Ireland Uc Dihydropyranopyrimidines for the treatment of viral infections
ES2912945T3 (es) 2016-09-29 2022-05-30 Janssen Sciences Ireland Unlimited Co Profármacos de pirimidina para el tratamiento de infecciones virales y otras enfermedades
TW201945003A (zh) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 ２，４－二胺基喹唑啉衍生物及其醫學用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518269B1 (en) * 2000-07-28 2003-02-11 University Of Arizona Foundation Cancer treatment
US6670357B2 (en) 2000-11-17 2003-12-30 Bristol-Myers Squibb Company Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors

Also Published As

Publication number Publication date
WO2003099286A1 (en) 2003-12-04
TW200407143A (en) 2004-05-16
US7030118B2 (en) 2006-04-18
EP1519729A1 (en) 2005-04-06
AU2003239568A1 (en) 2003-12-12
AR040081A1 (es) 2005-03-16
US20030232832A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
PE20040761A1 (es) Compuestos de pirrolotriazona
PE20050482A1 (es) Derivados de dihidrobenzofuranilo alcanamida
RU2009110913A (ru) Пиразольные ингибиторы daao
PE20071322A1 (es) Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa
AR038341A1 (es) Compuestos que son agonistas de receptores alfa-1 preferentemente agonistas de receptores alfa-1a/l
AR042525A1 (es) Derivados de pirrolo-pirazoles sustituidos como inhibidores de quinasa
ES2134835T3 (es) Derivados de piperazina como antagonistas de los receptores 5-ht.
ES2029786T3 (es) Procedimiento para preparar nuevos derivados de quinolina.
CO4520230A1 (es) Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptores
NO931317D0 (no) Et terapeutisk middel for parkinson's sykdom
SE0101579D0 (sv) New compounds
GB1148629A (en) s-triazolo(1,5-a) pyrimidines substituted in the 7-position by a basic group
AR039111A1 (es) Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas
ES8401321A1 (es) Procedimiento para la obtencion de derivados de piridina.
PL301611A1 (en) Anti-retroviral hydrazine derivatives
BR0010134A (pt) Uso de derivados de ácido 2,4-diamino-3-hidroxicarboxìlico como inibidores de proteassoma
IL75239A (en) Derivatives of 7-(1-(2-aminothiazol-4-yl)-ethen-carboxamido)-4-carboxy-3-cephemmethylaminium inner salt,their preparation,pharmaceutical compositions containing them and their use as growth-promoters in livestock rearing or as antioxidants
PE20030517A1 (es) Composicion fungicida a base de al menos un derivado de piridil-metil-benzamida y de al menos un derivado ditio-carbamato
DE3882795D1 (de) Bicyclische sulfonamidderivate, ihre herstellung, ihre anwendung und zubereitungen die sie enthalten.
PL352172A1 (en) Derivatives of n-alkoxyalkylo-n,n-dialkyloamine or salts thereof and the agents containing these compounds used in treatment of neurodegenerative diseases
DE3878863D1 (de) 2-tert.-butyl-5-isoxazolylmethylthio-3(2h)-pyridazin-3-on-derivate.
DK71586A (da) 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamider, deres fremstilling og anvendelse som herbicider
EA200400757A1 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
ES2194690T3 (es) Procedimiento de preparacion de oxazoles trisustituidos.
ATE27147T1 (de) Arylsulfonyl-harnstoff-derivate, ihre anwendung als herbizide und zusammensetzungen, die sie enthalten.

Legal Events

Date Code Title Description
FC Refusal